MedDeviceGuideMedDeviceGuide
Back

ESU Recalls: ConMed, Stryker, Megadyne & Olympus Surgical-Fire and Burn Teardown

A manufacturer-spanning deep dive into FDA electrosurgical unit (ESU) recalls and MAUDE adverse event reports. Analyzes 640 recalls, surgical fire risks, and QMS implications.

Ran Chen
Ran Chen
Global MedTech Expert | 10× MedTech Global Access
Published 2026-07-10Last reviewed 2026-07-1017 min read

Electrosurgery is one of the most common technologies in modern operating rooms, used in approximately 80 percent of all surgical procedures to cut tissue and control bleeding. Electrosurgical units (ESUs) use high-frequency electrical currents (typically 200 kHz to over 3 MHz) to generate intense thermal energy at the surgical site. Because this technology involves both high-voltage electricity and thermal energy, any device malfunction or operator error can lead to severe complications, including patient burns, operating room fires, and internal tissue damage.

For perioperative safety officers, OR clinical engineers, and sterile processing leads, managing electrosurgical safety requires understanding the post-market performance of these devices. This deep dive provides a manufacturer-spanning analysis of FDA recalls and adverse-event reports from the Manufacturer and User Facility Device Experience (MAUDE) database for electrosurgical units and accessories.


Executive Summary: Electrosurgical Safety

  • Recall Volume & Manufacturer Distribution: The FDA records 640 device recalls under product code GEI, which covers electrosurgical generators and accessories. The recall record is distributed across several key manufacturers, led by ConMed (88 recalls across name variants), Stryker (48 recalls), the CareFusion/BD lineage (45 recalls), the Covidien/Valleylab-to-Medtronic lineage (45 recalls), Olympus (33 recalls), Megadyne/Ethicon (31 recalls), and Encision (26 recalls).
  • MAUDE Signal Volume: Electrosurgical devices generate a significant safety footprint in the MAUDE database, reflecting their high usage rates in operating rooms:
    • In 2024, MAUDE recorded 7,900 reports under product code GEI, including 6,652 malfunctions, 1,186 patient injuries, and 23 deaths.
    • In 2025, MAUDE recorded 7,696 reports, including 6,475 malfunctions, 1,204 patient injuries, and 15 deaths.
  • Covidien/Valleylab Dominance in MAUDE: Covidien (Medtronic) and the Valleylab lineage account for the largest share of adverse events in MAUDE, totaling over 2,000 reports annually (2024: 2,068 reports under Covidien Mfg DC Boulder).
  • Primary Failure Modes: While operating room fires are the most severe risk, the leading root causes of official product recalls since 2020 are Under Investigation by Firm (118 recalls), Device Design (24 recalls), and Process Control (23 recalls).
  • Key Event Anchors:
    • Ethicon/Megadyne Class I Recall (July 2023): The largest recent ESU recall involved thousands of reusable MEGA 2000 and MEGA SOFT patient-return-electrode pads due to reports of pediatric and adult patient burns (63 injuries, 0 deaths).
    • Olympus instrument Recall Cluster (2026): In early 2026, Olympus recalled 11 instrument models (Thunderbeat, Everest, PK) due to insulation degradation and mechanical tip failures.

ESU Product Codes and Regulatory Classification

The FDA regulates electrosurgical generators and their accessories under a broad range of product codes, depending on the energy type (monopolar, bipolar, advanced bipolar, plasma, argon gas) and the specific application (general surgery, neurosurgery, gynecology, urology):

Product Code FDA Device Name FDA Device Class Regulation Primary Use
GEI Electrosurgical, Cutting & Coagulation & Accessories Class II 21 CFR 878.4400 General-surgery RF generators, pencils, and accessories
FAR Unit, Electrosurgical Class II 21 CFR 876.4300 General electrosurgery generators
BWA Unit, Electrosurgical And Coagulation, With Accessories Class II 21 CFR 878.4400 Bipolar / vessel-sealing instruments
KNS Unit, Electrosurgical, Endoscopic Class II 21 CFR 876.4300 Endoscopic electrosurgery (GI/urology)
HAM Apparatus, Electrosurgical Class II 21 CFR 878.4400 General electrosurgical apparatus
DWG Electrosurgical Device Class II 21 CFR 878.4400 Electrosurgical devices and accessories

Note: Product code GEI is the primary code used for post-market surveillance of general surgery electrosurgical systems, covering both the RF generators and the sterile disposables (pencils, tips, cords, dispersive electrodes).


Electrosurgical Physics: Waveforms and Thermal Effects

To understand the post-market safety profile of ESUs, we must first analyze the fundamental physics of radiofrequency (RF) tissue interaction. Electrosurgical generators produce high-frequency alternating current that bypasses neuromuscular stimulation (which ceases above 10 kHz) to create thermal tissue effects.

Monopolar Cut vs. Coagulation Waveforms

  • Pure Cut: A continuous, low-voltage, high-frequency sinusoidal wave (100% duty cycle). This creates rapid cellular heating, causing cells to explode and vaporize, resulting in a clean incision with minimal thermal damage to surrounding tissue.
  • Coagulation (Desiccation / Fulguration): A pulsed, high-voltage, low-frequency wave (typically a 6% to 10% duty cycle). This produces slower heating, dehydrating cells (desiccation) or creating superficial carbonization (fulguration) to seal blood vessels.
  • Crest Factor and Insulation Stress: The "Crest Factor" is the ratio of peak voltage to root-mean-square (RMS) voltage. Pure cut has a crest factor of ~1.4, while coagulation modes can have crest factors exceeding 8.0. High crest factors place significant electrical stress on the instrument's insulation. During coagulation, the high peak voltages (often exceeding 5,000V) are much more likely to cause dielectric breakdown and spark through micro-cracks in laparoscopic insulation.

Recommended Reading
FDA 510(k) Predicate Best Practices: Recall History, Creep, and the 2026 QMSR Gate
Regulatory Quality Systems2026-07-06 · 17 min read

Detailed Failure Mode Analysis: Why ESUs Fail

To manage an ESU fleet effectively, safety managers must understand the specific electrical and mechanical failure modes that occur in the field:

Common ESU Failure Modes
 ├── Return-Electrode Pad Burn ──> High Current Density (Poor Contact Area)
 ├── Active-Electrode Insulation ──> Dielectric Breakdown (Stray Current in Tissue)
 ├── Capacitive Coupling ──────────> Stray Current (Energy Transfer via Inductive Fields)
 └── Surgical Fire ────────────────> Thermal Energy + Flammable Prep Agents + Oxygen

1. Patient-Return-Electrode (Dispersive Pad) Burns

In monopolar electrosurgery, the electrical current must travel from the generator, through the active electrode, through the patient's body, and return to the generator via a large dispersive pad (return electrode).

  • The Failure: If the return pad is partially detached, or if the gel dries out, the contact area is reduced.
  • The Outcome: High current density. Because the same amount of current must pass through a smaller area, the temperature rises rapidly, causing severe third-degree burns at the pad site. Modern generators use Contact Quality Monitoring (CQM) systems (e.g., Valleylab REM) to detect impedance changes, but these systems can fail if the pad's gel is compromised or if the pad is applied over scar tissue.

2. Active-Electrode Insulation Failures

Active electrodes (pencils, laparoscopic shears) are covered with a protective layer of polymer insulation to prevent electrical energy from escaping to surrounding tissue.

  • The Failure: The insulation can degrade over time due to repeated sterilization or high voltage, or it can develop microscopic cracks (dielectric breakdown).
  • The Outcome: Stray current leakage. The electrical energy will escape through the insulation defect and burn adjacent organs (e.g., bowel, bladder) during laparoscopic surgery, often without the surgeon realizing it.

3. Active-Electrode Insulation Integrity Testing (Sterile Processing)

Laparoscopic insulation defects are often invisible to the naked eye. To address this risk, Sterile Processing Departments (SPD) must implement electronic insulation testing during instrument reprocessing.

  • Low-Voltage Sponge Testing: The instrument is passed through a wet sponge connected to a low-voltage circuit. If there is a break in the insulation, the circuit completes, triggering an audible alarm.
  • High-Voltage Pore Testing: A high-voltage wand (typically 2.0 to 4.5 kV) is passed along the shaft of the dry instrument. Any microscopic crack or pinhole will cause an electrical arc (spark) to jump from the wand to the metal shaft, indicating a failure.
  • Operational Rule: Any instrument that fails insulation testing must be immediately flagged, removed from the set, and sent for repair or discard. Relying on visual inspection alone is a significant safety risk that leads to unrecognized patient injury.

4. Capacitive Coupling and Shielding Systems

This is a physical phenomenon where electrical energy is transferred from the active electrode, through intact insulation, to an adjacent conductive material (such as a metal cannula).

  • The Failure: High voltage and high-frequency currents generate electromagnetic fields that induce current in nearby instruments.
  • The Outcome: Stray current burns. If the metal cannula is not grounded, the induced current will seek a path to ground through the patient's internal organs, leading to unrecognized bowel perforations.
  • Active Electrode Monitoring (AEM) Mitigation: Manufacturers like Encision have developed AEM technology to prevent this. AEM utilizes a dynamically shielded instrument design with a built-in protective shield. This shield intercepts any capacitive coupling or stray current leakage and returns it directly to the generator's return pathway, automatically shutting down the generator if a fault threshold is crossed. OR leads should prioritize AEM systems for high-voltage monopolar procedures.

5. Operating Room and Airway Fires

The operating room environment is rich in oxygen and nitrous oxide, creating a classic fire triangle when combined with ESU thermal energy.

  • The Failure: The ESU active electrode generates temperatures exceeding 1,000°C. If the active electrode is activated near flammable prep agents (e.g., alcohol-based prep) or surgical drapes in an oxygen-rich environment:
  • The Outcome: An immediate surgical fire.
  • Airway Fire Vulnerability: Airway procedures, such as tracheostomies and head/neck resections, represent the highest-risk scenarios. When entering the trachea, the local oxygen concentration can reach 50–100%. If the surgeon uses the ESU pencil to incise the trachea in the presence of leaking oxygen from the endotracheal tube, the tube can ignite, acting as a blowtorch inside the patient's airway. Safe surgical practice dictates dropping the inspired oxygen concentration (FiO2) below 30% before entering the airway.

Operating Room Surgical Smoke Plume Hazards

In addition to electric shock and thermal burns, the use of ESUs generates significant volumes of surgical smoke (plume). This plume is not merely a nuisance; it is a biohazard.

Chemical and Biological Composition

Surgical smoke contains:

  • Toxic Chemicals: Benzene, formaldehyde, toluene, and hydrogen cyanide, which are known carcinogens and respiratory irritants.
  • Aerosolized Biological Materials: Blood fragments, cellular debris, and viable viral particles (including HPV and HIV) and bacterial DNA.
  • Respiratory Load: Breathing the smoke plume from a typical day of electrosurgery is equivalent to smoking 27 to 30 cigarettes.

Regulatory and Safety Mandates

To mitigate this risk, professional organizations (such as AORN and NIOSH) and international standards (ISO 16571) recommend the use of dedicated Local Exhaust Ventilation (LEV) or smoke evacuation systems. These systems utilize Ultra-Low Penetration Air (ULPA) filters to capture sub-micron particles. Hospital QMS and clinical engineering teams must ensure that smoke evacuator suction is activated within 2 inches of the surgical site to capture the plume before it disperses into the OR air.


QMS and Manufacturing Quality Systems Implications (21 CFR Part 820)

Analyzing the root causes of GEI recalls since 2020 reveals where manufacturing quality systems fail:

  1. Under Investigation by Firm (118 recalls since 2020): This category indicates that manufacturers frequently identify post-market safety trends through internal audits or customer complaints. Under 21 CFR 820.100 (Corrective and Preventive Action - CAPA), manufacturers must maintain robust procedures to analyze adverse events, identify root causes, and implement corrective actions to prevent recurrence.
  2. Device Design (24 recalls since 2020): Hardware design flaws that make the device vulnerable to moisture ingress or electrostatic discharge (ESD).
  3. Process Control (23 recalls since 2020): Assembly failures, such as inadequate soldering on circuit boards, which can lead to open circuits when the device is subjected to vehicle vibrations in ambulances or police cruisers.
  4. Nonconforming Material / Component (7 recalls since 2020): ESU manufacturers rely on external suppliers for RF generator components, insulation polymers, and dispersive-electrode gels. If a supplier changes their manufacturing process without notifying the device manufacturer, or if incoming inspection fails to detect component defects, the ESU's QMS is compromised.

Design Verification and Dielectric Testing

For manufacturers of electrosurgical instruments, design verification must include high-voltage dielectric strength testing under simulated clinical conditions (moisture, mechanical stress, thermal cycling). Verification testing should confirm that the insulation can withstand up to 10,000V RF peak-to-peak without dielectric breakdown. If design verification fails to test the limits of insulation wear over multiple sterilization cycles, the device is likely to generate post-market injury reports in MAUDE.


Recommended Reading
Custom-Made Medical Devices Under EU MDR: Annex XIII and the FDA Exemption
EU MDR / IVDR Manufacturing2026-07-08 · 20 min read

MAUDE Adverse Events Deep Dive

While recall notices target specific lots, the MAUDE database reveals the continuous, daily volume of adverse events reported in the field. Filtering the 25-million-row MAUDE database for ESU product codes (GEI) reveals a massive safety footprint:

Annual MAUDE ESU Report Volumes (2024 vs. 2025)

The volume of reported malfunctions and injuries is exceptionally high, reflecting the broad use of electrosurgical energy across nearly every surgical specialty:

Metric 2024 Reports 2025 Reports 2-Year Trend / Notes
Total ESU Reports 7,900 7,696 Extremely high post-market reporting footprint
Device Malfunctions 6,652 (84.2%) 6,475 (84.1%) Dominant category; typically insulation/cord alerts
Patient Injuries 1,186 (15.0%) 1,204 (15.6%) Burns at the return-electrode pad site or from stray current
Flagged Deaths 23 (0.3%) 15 (0.2%) Patient died during a procedure involving electrosurgical energy
Other / Unclassified 39 2 Reporting anomalies

Manufacturer Concentration in MAUDE (2024)

Analyzing the manufacturer field in the 2024 MAUDE dataset reveals which brands dominate the clinical adverse-event record:

  1. Covidien / Valleylab lineage: 2,068 reports under "Covidien Mfg DC Boulder." Covidien represents approximately 26.2% of all electrosurgery reports in MAUDE. This concentration is driven by two main factors: the dominant installed base of Valleylab/ForceTriad generators in hospital operating rooms, and the high reporting volume from their ForceTriad generators and LigaSure vessel-sealing instruments used across general surgery.
  2. Maquet Cardiovascular: 1,066 reports. Primarily driven by endoscopic vessel-harvesting and sealing instrumentation.
  3. Olympus: 572 reports in 2024 under one Olympus manufacturing entity (with additional reports under affiliated Olympus entities). Primarily driven by the Thunderbeat family of advanced-bipolar/ultrasonic instruments.

High-Acuity Case Studies

To understand how these failures impact clinical operations, we must examine two major post-market events.

1. The July 2023 Megadyne Patient-Return-Electrode Pad Recall

The largest recent ESU recall targeted the Megadyne MEGA 2000 and MEGA SOFT reusable patient-return-electrode pads, affecting thousands of units in circulation.

  • The Failure Mode: The reusable return pad, designed to be placed under the patient on the operating table, was linked to reports of severe patient burns (including third-degree burns) in both pediatric and adult patients. The root cause was associated with variations in current density and moisture accumulation under the patient during long procedures.
  • Clinical and Legal Impact: The FDA designated this as a Class I Recall in July 2023 due to the risk of life-threatening burn injuries. While 0 patient deaths were reported, the event forced hospital OR teams to suspend the use of reusable pads and transition back to single-use disposable return electrodes.

2. 2026 Olympus Instrument Recall Cluster

Post-market actions for electrosurgical instruments remain active through 2026:

  • Olympus Thunderbeat II Shears Recall (March 2026): Olympus recalled specific models of their Thunderbeat II shears (TB2-0525FC, TB2-0520FC, TB2-0535FC, TB2-0545FC) due to a manufacturing defect in the insulation layer of the active tip, which could lead to stray current leakage and patient burns.
  • Olympus PK Cutting Forceps Recall (February 2026): Specific models of Olympus PK Cutting Forceps and Everest Bipolar Cutting Forceps were recalled due to mechanical failure of the cutting mechanism, which could result in tissue tearing or retained foreign objects in the surgical site.

Sibling Device Comparison: Electrosurgical Units vs. Other OR Devices

To put this data in perspective, we can compare ESU safety profiles with other OR-based devices we have analyzed, including surgical stapler recalls and infusion pump recalls:

Feature / Metric Electrosurgical Units Infusion Pumps Surgical Staplers
FDA Product Codes GEI FRN GAG
Typical Setting Operating Rooms, Surgical Centers ICU, General Wards, Operating Rooms Operating Rooms, Surgical Centers
Primary User Surgeons, Surgical Techs Nurses, Anesthesiologists Surgeons, Surgical Techs
Post-Market Report Volume High (~7,900 reports/yr) Very High (~250,000 reports/yr) Moderate (~2,000–2,500 reports/yr)
Key Mechanical Failure Insulation cracking, cord fracture Tubing occlusion, door latch failure Staple malformation, jam
Key Electrical Failure Generator RF drift, circuit board short Battery depletion, sensor drift Battery depletion (for powered staplers)
Clinical Vulnerability Direct thermal energy application High medication dosing errors Immediate tissue transection failure
Regulatory Status Class II (510k) Class II (510k) Class II (510k)

Recommended Reading
FDA Insulin Pump Recalls: Medtronic, Insulet, and Tandem — A MAUDE and Class I Teardown
Regulatory Post-Market Surveillance2026-06-25 · 20 min read

Actionable Recommendations for OR Nurse Managers and Safety Officers

Based on this post-market surveillance data, facility safety managers and clinical engineers should implement the following steps:

  1. Act on the Megadyne MEGA Return-Electrode Recall: For facilities that used Megadyne MEGA 2000 or MEGA SOFT reusable patient-return electrodes, follow the manufacturer's and FDA's recommended actions, monitor patients post-operatively as advised, and transition affected cases to single-use disposable return electrodes where the reusable pads are implicated in burn reports.
  2. Implement Return-Electrode and Accessory Rotation: Do not wait for a pad to fail mid-procedure. Track use cycles on reusable return electrodes, inspect gel integrity before each case, and store dispersive pads per the manufacturer's temperature range (typically 15°C to 35°C) to prevent the conductive gel from drying out or degrading.
  3. Perform Post-Incident MAUDE Audits: If an ESU causes or contributes to a patient burn, an OR fire, or a stray-current injury, do not simply return the unit to service. Pull the generator's internal use log, inspect the active and return accessories for insulation damage, and file a report in MAUDE so that systemic failure patterns stay visible.
  4. Reconcile Corporate Name Variants: Ensure asset-management and recall-tracking systems map historical corporate names to the current entity — Valleylab and Covidien are now under Medtronic, Megadyne is under Ethicon/J&J, CareFusion is now BD, while Erbe and ConMed remain independent. This is critical for receiving and acting on ESU recall notices.
  5. Verify Supplier Quality Agreements: For ESU manufacturers, establish strict Quality Agreements with component suppliers (RF generator modules, insulation polymers, and dispersive-electrode gels). Enforce incoming inspection that subjects insulation to high-voltage dielectric stress to identify defects before assembly.
  6. Implement High-Voltage Insulation Audits in Sterile Processing: Ensure the sterile processing department utilizes high-voltage wands (pore testers) on all reusable laparoscopic electrosurgical shafts during set assembly. Visual inspection is insufficient to capture micro-cracks that leak stray current.

Frequently Asked Questions

Has an electrosurgical unit been recalled as Class I?

Yes. The FDA has issued multiple Class I designations for electrosurgical units and accessories. The most common causes are return-electrode pad defects (e.g., the Megadyne recall), active-electrode insulation failures, and generator software anomalies that prevent the device from delivering a therapeutic RF waveform.

How many burn and fire injuries are reported in MAUDE for electrosurgical devices?

MAUDE records approximately 1,100 to 1,200 patient injuries annually associated with electrosurgical devices. These reports represent incidents where a patient sustained a burn or other injury during a procedure; they do not necessarily prove that the ESU caused the injury, but they are a critical indicator of device performance.

What failed with the Ethicon/Megadyne return-electrode pads and how many were recalled?

Megadyne recalled thousands of MEGA 2000 and MEGA SOFT reusable return-electrode pads due to reports of pediatric and adult patient burns. The root cause was associated with variations in current density and moisture accumulation under the patient during long procedures.

Which electrosurgical brand has the most recalls or MAUDE reports?

Covidien (Medtronic) and the Valleylab lineage account for the largest share of adverse events in MAUDE, totaling over 2,000 reports annually. This is primarily due to their large installed base of ForceTriad generators and LigaSure vessel-sealing instruments across professional operating rooms.

Are electrosurgical surgical fires still a leading OR hazard?

Yes. Electrosurgical surgical fires remain a leading OR hazard, typically caused by the combination of an ESU active electrode (which generates temperatures exceeding 1,000°C), flammable prep agents (such as alcohol-based prep), and an oxygen-rich environment.